glp-1 nutrition nestle GLP‑1 Disruption, Nestlé's Strategy Shift and Reformulation Pressure rounded diet containing the appropriate intake and incorporating meal replacement shakes Complement Your Weight Management Journey
Description
Still, Ro is a reliable choice if you want a program that combines convenience with long-term results
GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity
CNS Neurosci
Heart 11 (4), 393397
"The ability of semaglutide to significantly lower cardiovascular and COVID-19-related adverse events underscores the transformative potential of targeting obesity and improving cardiometabolic health as a strategy to protect against a broad spectrum of health threats." In the sex differences substudy, researchers found females experienced fewer major adverse cardiovascular events compared to males, but semaglutide consistently reduced the risk of adverse cardiovascular outcomes regardless of sex
Abstract This narrative review synthesizes evidence identified through targeted searches of PubMed, Scopus, and Web of Science (2010-2025), with a focused selection of human and mechanistic studies examining GLP-1 receptor agonists (GLP-1s), food cue reactivity, prospective cognition, mindfulness-based interventions, and neural network dynamics relevant to 'food noise' and the default mode network (DMN)
